{"id":933571,"date":"2026-02-03T08:03:43","date_gmt":"2026-02-03T13:03:43","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/genedx-to-report-fourth-quarter-2025-financial-results-on-monday-february-23-2026\/"},"modified":"2026-02-03T08:03:43","modified_gmt":"2026-02-03T13:03:43","slug":"genedx-to-report-fourth-quarter-2025-financial-results-on-monday-february-23-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/genedx-to-report-fourth-quarter-2025-financial-results-on-monday-february-23-2026\/","title":{"rendered":"GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026"},"content":{"rendered":"

<\/p>\n

GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026<\/b><\/p>\n

GAITHERSBURG, Md.–(BUSINESS WIRE<\/a>)–
\nGeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced it will release financial results for the fourth quarter of 2025 before the market opens on Monday, February 23, 2026. Management will host a conference call that day to discuss fourth quarter 2025 financial and operating results at 8:30 a.m. Eastern Time.<\/p>\n

\nConference Call Details<\/p>\n

\nInvestors interested in listening to the conference call are required to register online. A live and archived webcast of the event will be available on the \u201cEvents\u201d section of the GeneDx investor relations website at https:\/\/ir.genedx.com\/<\/a>.<\/p>\n

About GeneDx<\/b><\/p>\n

\nGeneDx (Nasdaq: WGS) is the global leader in rare disease diagnosis, with a mission to empower everyone to live their healthiest life through genomics. GeneDx combines unmatched clinical expertise, advanced technology, and the power of GeneDx Infinity\u2122 \u2013 the world\u2019s largest rare disease genomic dataset. This unparalleled foundation powers GeneDx\u2019s ExomeDx\u2122 and GenomeDx\u2122 tests \u2013 ranked #1 by expert geneticists and granted FDA Breakthrough Device Designation \u2013 enabling clinicians to deliver precise, fast, and actionable diagnoses. GeneDx Infinity also fuels discovery for biopharma with the most powerful AI-driven genomic intelligence. A genomics pioneer over the last 25 years, diagnosing more than 4,800 genetic diseases and publishing more than 1,000 research publications, GeneDx is building the network that will drive the future of genomic precision medicine. For more information, visit genedx.com<\/a> and connect with us on LinkedIn<\/a>, Facebook<\/a>, and Instagram<\/a>.<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20260203915280\/en\/<\/a><\/span><\/p>\n

Investor Relations Contact:
\n<\/b>
Investors@GeneDx.com
\n<\/a><\/p>\n

Media Contact:
\n<\/b>
Press@GeneDx.com<\/a><\/p>\n

KEYWORDS:<\/b> United States North America New York Maryland<\/p>\n

INDUSTRY KEYWORDS:<\/b> Biotechnology Managed Care Health General Health Healthcare Reform Pharmaceutical Medical Devices Hospitals Genetics Public Policy\/Government Clinical Trials<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026 GAITHERSBURG, Md.–(BUSINESS WIRE)– GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced it will release financial results for the fourth quarter of 2025 before the market opens on Monday, February 23, 2026. Management will host a conference call that day to discuss fourth quarter 2025 financial and operating results at 8:30 a.m. Eastern Time. Conference Call Details Investors interested in listening to the conference call are required to register online. A live and archived webcast of the event will be available on the \u201cEvents\u201d section of the GeneDx investor relations website at https:\/\/ir.genedx.com\/. About GeneDx GeneDx (Nasdaq: WGS) is the global … <\/p>\n

Continue reading “GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-933571","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nGeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/genedx-to-report-fourth-quarter-2025-financial-results-on-monday-february-23-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026 GAITHERSBURG, Md.–(BUSINESS WIRE)– GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced it will release financial results for the fourth quarter of 2025 before the market opens on Monday, February 23, 2026. Management will host a conference call that day to discuss fourth quarter 2025 financial and operating results at 8:30 a.m. Eastern Time. Conference Call Details Investors interested in listening to the conference call are required to register online. A live and archived webcast of the event will be available on the \u201cEvents\u201d section of the GeneDx investor relations website at https:\/\/ir.genedx.com\/. About GeneDx GeneDx (Nasdaq: WGS) is the global … Continue reading "GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/genedx-to-report-fourth-quarter-2025-financial-results-on-monday-february-23-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-03T13:03:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260203915280r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genedx-to-report-fourth-quarter-2025-financial-results-on-monday-february-23-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genedx-to-report-fourth-quarter-2025-financial-results-on-monday-february-23-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026\",\"datePublished\":\"2026-02-03T13:03:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genedx-to-report-fourth-quarter-2025-financial-results-on-monday-february-23-2026\\\/\"},\"wordCount\":312,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genedx-to-report-fourth-quarter-2025-financial-results-on-monday-february-23-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260203915280r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genedx-to-report-fourth-quarter-2025-financial-results-on-monday-february-23-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genedx-to-report-fourth-quarter-2025-financial-results-on-monday-february-23-2026\\\/\",\"name\":\"GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genedx-to-report-fourth-quarter-2025-financial-results-on-monday-february-23-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genedx-to-report-fourth-quarter-2025-financial-results-on-monday-february-23-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260203915280r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2026-02-03T13:03:43+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genedx-to-report-fourth-quarter-2025-financial-results-on-monday-february-23-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genedx-to-report-fourth-quarter-2025-financial-results-on-monday-february-23-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genedx-to-report-fourth-quarter-2025-financial-results-on-monday-february-23-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260203915280r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260203915280r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genedx-to-report-fourth-quarter-2025-financial-results-on-monday-february-23-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/genedx-to-report-fourth-quarter-2025-financial-results-on-monday-february-23-2026\/","og_locale":"en_US","og_type":"article","og_title":"GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026 - Market Newsdesk","og_description":"GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026 GAITHERSBURG, Md.–(BUSINESS WIRE)– GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced it will release financial results for the fourth quarter of 2025 before the market opens on Monday, February 23, 2026. Management will host a conference call that day to discuss fourth quarter 2025 financial and operating results at 8:30 a.m. Eastern Time. Conference Call Details Investors interested in listening to the conference call are required to register online. A live and archived webcast of the event will be available on the \u201cEvents\u201d section of the GeneDx investor relations website at https:\/\/ir.genedx.com\/. About GeneDx GeneDx (Nasdaq: WGS) is the global … Continue reading \"GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/genedx-to-report-fourth-quarter-2025-financial-results-on-monday-february-23-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-02-03T13:03:43+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260203915280r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genedx-to-report-fourth-quarter-2025-financial-results-on-monday-february-23-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genedx-to-report-fourth-quarter-2025-financial-results-on-monday-february-23-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026","datePublished":"2026-02-03T13:03:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genedx-to-report-fourth-quarter-2025-financial-results-on-monday-february-23-2026\/"},"wordCount":312,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genedx-to-report-fourth-quarter-2025-financial-results-on-monday-february-23-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260203915280r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genedx-to-report-fourth-quarter-2025-financial-results-on-monday-february-23-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/genedx-to-report-fourth-quarter-2025-financial-results-on-monday-february-23-2026\/","name":"GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genedx-to-report-fourth-quarter-2025-financial-results-on-monday-february-23-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genedx-to-report-fourth-quarter-2025-financial-results-on-monday-february-23-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260203915280r1&sid=flmnd&distro=nx&lang=en","datePublished":"2026-02-03T13:03:43+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genedx-to-report-fourth-quarter-2025-financial-results-on-monday-february-23-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/genedx-to-report-fourth-quarter-2025-financial-results-on-monday-february-23-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genedx-to-report-fourth-quarter-2025-financial-results-on-monday-february-23-2026\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260203915280r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260203915280r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genedx-to-report-fourth-quarter-2025-financial-results-on-monday-february-23-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/933571","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=933571"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/933571\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=933571"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=933571"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=933571"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}